Mutant valosin-containing protein causes a novel type of frontotemporal dementia

Annals of Neurology

Volumn 57, Issue 3, 2005, Pages 457-461

  Schröder, Rolf ^a,b   Watts, Giles D J ^c   Mehta, Sarju G ^c   Evert, Bernd O ^a   Broich, Petra ^a   Fließbach, Klaus ^a   Pauls, Katharina ^a   Hans, Volkmar H ^a   Kimonis, Virginia ^c   Thal, Dietmar R ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPSY; CASE REPORT; CELL INCLUSION; CENTRAL NERVOUS SYSTEM; CHROMOSOME 9P; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MISSENSE MUTATION; NERVE CELL; PAGET BONE DISEASE; PRIORITY JOURNAL; VALOSIN CONTAINING PROTEIN GENE;

AMYLOID BETA-PROTEIN PRECURSOR; ARGININE; BLOTTING, WESTERN; BRAIN; CELL CYCLE PROTEINS; CYSTEINE; DEMENTIA; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION, MISSENSE; STAINING AND LABELING; TAU PROTEINS; UBIQUITIN;

EID: 20044373638     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20407     Document Type: Article

References (20)

1. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377-381.
2. Hetzer M, Meyer HH, Walther TC, et al. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. Nat Cell Biol 2001;3:1086-1091.
3. Rabouille C, Kondo H, Newman R, et al. Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell 1998;92:603-610.
4. Kondo H, Rabouille C, Newman R, et al. p47 is a cofactor for p97-mediated membrane fusion. Nature 1997;388:75-78.
5. Meyer HH, Shorter JG, Seemann J, et al. A complex of mammalian ufd1 and np14 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J 2000;19:2181-2192.
6. Rabinovich E, Kerem A, Frohlich KU, et al. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 2002; 22:626-634.
7. Hirabayashi M, Inoue K, Tanaka K, et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 2001;8:977-984.
8. Dai RM, Li CC. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 2001;3:740-744.
9. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991; 1:213-216.
10. Otvos L Jr, Feiner L, Lang E, et al. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994;39:669-673.
11. Jicha GA, Lane E, Vincent I, et al. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J Neurochem 1997;69: 2087-2095.
12. Lie AA, Schroder R, Blumcke I, et al. Plectin in the human central nervous system: predominant expression at pia/glia and endothelia/glia interfaces. Acta Neuropathol (Berl) 1998;96: 215-221.
13. Sautiere PE, Sindou P, Couratier P, et al. Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach. Neurosci Lett 1992;140:206-210.
14. Mackenzie IR, Feldman H. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases. Dement Geriatr Cogn Disord 2004;17:333-336.
15. Rosso SM, Kamphorst W, de Graaf B, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 2001;124:1948-1957.
16. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol (Berl) 2001;102:94-102.
17. Ghetti B, Hutton ML, Wszolek ZK. Frontotemporal dementia and Parkinsonism linked to chromosome 17 with Tau Gene mutations (FTDP-17T). In: Dickson D, ed. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel, Switzerland: ISN Neuropath Press, 2003:86-102.
18. Lowe J, Rossor M. Frontotemporal lobar degeneration. In: Dickson D, ed. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel, Switzerland: ISN Neuropath Press, 2003:342-348.
19. Dai RM, Chen E, Longo DL, et al. Involvement of valosin-containing protein, an ATPase co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 1998;273:3562-3573.
20. Brizzee KR, Cancilla PA, Sherwood N, Timiras PS. The amount and distribution of pigments in neurons and glia of the cerebral cortex. Autofluorescent and ultrastructural studies. J Gerontol 1969;24:127-135.